Annexin Pharmaceuticals AB Sweden

First patient treated in the second dose group in Annexin's RVO study

View original content:https://www.prnewswire.co.uk/news-releases/first-patient-treated-in-the-second-dose-group-in-annexins-rvo-study-301966941.html